2130 related articles for article (PubMed ID: 17063088)
1. Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.
Abraham SC; Kamath PS; Eghtesad B; Demetris AJ; Krasinskas AM
Am J Surg Pathol; 2006 Nov; 30(11):1454-61. PubMed ID: 17063088
[TBL] [Abstract][Full Text] [Related]
2. Liver transplantation for severe intrahepatic noncirrhotic portal hypertension.
Krasinskas AM; Eghtesad B; Kamath PS; Demetris AJ; Abraham SC
Liver Transpl; 2005 Jun; 11(6):627-34; discussion 610-1. PubMed ID: 15915493
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
[TBL] [Abstract][Full Text] [Related]
4. Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests.
Abraham SC; Poterucha JJ; Rosen CB; Demetris AJ; Krasinskas AM
Am J Surg Pathol; 2008 Jul; 32(7):965-73. PubMed ID: 18460980
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma and nodular regenerative hyperplasia: possible pathogenetic relationship.
Nzeako UC; Goodman ZD; Ishak KG
Am J Gastroenterol; 1996 May; 91(5):879-84. PubMed ID: 8633575
[TBL] [Abstract][Full Text] [Related]
6. Pathology of the liver in "idiopathic portal hypertension" associated with autoimmune disease. The Ministry of Health and Welfare Disorders of Portal Circulation Research Committee.
Nakanuma Y; Nonomura A; Hayashi M; Doishita K; Takayanagi N; Uchida T; Obata Y; Noma K; Ikoma J; Yoshikawa K
Acta Pathol Jpn; 1989 Sep; 39(9):586-92. PubMed ID: 2596298
[TBL] [Abstract][Full Text] [Related]
7. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma.
Heimbach JK; Gores GJ; Haddock MG; Alberts SR; Pedersen R; Kremers W; Nyberg SL; Ishitani MB; Rosen CB
Transplantation; 2006 Dec; 82(12):1703-7. PubMed ID: 17198263
[TBL] [Abstract][Full Text] [Related]
8. Non-cirrhotic portal hypertension (obliterative portal venopathy) is the predominant form of chronic liver disease in cystic fibrosis.
ONeill JP; Clifford CS; Nolan NP; McCormick PA
Ir J Med Sci; 2023 Aug; 192(4):1657-1660. PubMed ID: 36114932
[TBL] [Abstract][Full Text] [Related]
9. Caroli's disease and orthotopic liver transplantation.
Habib S; Shakil O; Couto OF; Demetris AJ; Fung JJ; Marcos A; Chopra K
Liver Transpl; 2006 Mar; 12(3):416-21. PubMed ID: 16498655
[TBL] [Abstract][Full Text] [Related]
10. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: a single-center study.
Dupuis-Girod S; Chesnais AL; Ginon I; Dumortier J; Saurin JC; Finet G; Decullier E; Marion D; Plauchu H; Boillot O
Liver Transpl; 2010 Mar; 16(3):340-7. PubMed ID: 20209594
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic portal venopathy and related disorders of the liver.
Chawla Y; Dhiman RK
Semin Liver Dis; 2008 Aug; 28(3):270-81. PubMed ID: 18814080
[TBL] [Abstract][Full Text] [Related]
13. Nodular regenerative hyperplasia of the liver with and without portal hypertension: a comparison.
Harada A; Nakanuma Y; Govindarajan S; Peters RL
Ann Clin Lab Sci; 1986; 16(2):155-62. PubMed ID: 3963734
[TBL] [Abstract][Full Text] [Related]
14. Nodular regenerative hyperplasia of the liver: survival and associated features in a UK case series.
Morris JM; Oien KA; McMahon M; Forrest EH; Morris J; Stanley AJ; Campbell S
Eur J Gastroenterol Hepatol; 2010 Aug; 22(8):1001-5. PubMed ID: 20075739
[TBL] [Abstract][Full Text] [Related]
15. Portosystemic shunt versus orthotopic liver transplantation for the Budd-Chiari syndrome.
Shaked A; Goldstein RM; Klintmalm GB; Drazan K; Husberg B; Busuttil RW
Surg Gynecol Obstet; 1992 Jun; 174(6):453-9. PubMed ID: 1595020
[TBL] [Abstract][Full Text] [Related]
16. Nodular regenerative hyperplasia of the liver in hematologic disorders: a possible response to obliterative portal venopathy. A morphometric study of nine cases with an hypothesis on the pathogenesis.
Wanless IR; Godwin TA; Allen F; Feder A
Medicine (Baltimore); 1980 Sep; 59(5):367-79. PubMed ID: 7432153
[TBL] [Abstract][Full Text] [Related]
17. Nodular regenerative hyperplasia of the liver. A review of 14 cases.
Arvanitaki M; Adler M
Hepatogastroenterology; 2001; 48(41):1425-9. PubMed ID: 11677979
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and clinical significance of nodular regenerative hyperplasia in liver biopsies.
Barge S; Grando V; Nault JC; Broudin C; Beaugrand M; Ganne-Carrié N; Roulot D; Ziol M
Liver Int; 2016 Jul; 36(7):1059-66. PubMed ID: 26415006
[TBL] [Abstract][Full Text] [Related]
20. Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities.
Malamut G; Ziol M; Suarez F; Beaugrand M; Viallard JF; Lascaux AS; Verkarre V; Bechade D; Poynard T; Hermine O; Cellier C
J Hepatol; 2008 Jan; 48(1):74-82. PubMed ID: 17998147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
